Novel Therapeutic Targets for Antiarrhythmic Drugs
Summary
The feel-good place to buy books
Novel Therapeutic Targets for Antiarrhythmic Drugs by George Edward Billman
This book provides a comprehensive overview of several promising novel drug targets and approaches against arrhythmias, with particular emphasis placed on malignant ventricular arrhythmias.
"In Summary, the book is a good, comprehensive reference for knowledge on arrhythmia and its treatment, and is considered as worthwhile addition to the literature on cardiac arrhythmia and antiarrhythmic drugs" (ChemMedChem, July 2010)
GEORGE EDWARD BILLMAN is a professor at The Ohio State University. He is currently an Associate Editor of Pharmacology and Therapeutics, an Editor of Experimental Physiology, and on the editorial boards of Journal of Cardiovascular Pharmacology and Journal of Applied Physiology. Dr. Billman has authored over 125 journal articles and has been an invited speaker at twenty national and international scientific meetings. He wrote the chapter "Cardiac Sarcolemmal ATP-Sensitive Potassium Channel Antagonists" in Drug Discovery Handbook (Wiley).
| SKU | Unavailable |
| ISBN 13 | 9780470261002 |
| ISBN 10 | 0470261005 |
| Title | Novel Therapeutic Targets for Antiarrhythmic Drugs |
| Author | George Edward Billman |
| Condition | Unavailable |
| Binding Type | Hardback |
| Publisher | Wiley |
| Year published | 2010-01-26 |
| Number of pages | 616 |
| Cover note | Book picture is for illustrative purposes only, actual binding, cover or edition may vary. |
| Note | Unavailable |